Literature DB >> 20380008

NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.

Maria Gazouli1, Ioanna Pachoula, Ioanna Panayotou, Gerassimos Mantzaris, George Chrousos, Nicholas P Anagnou, Eleftheria Roma-Giannikou.   

Abstract

AIM: To assess whether the polymorphisms of NOD2/CARD15, autophagy-related 16-like 1 (ATG16L1), and interleukin-23 receptor (IL23R) genes play a more critical role in the susceptibility of childhood-onset than in adult-onset Crohn's disease (CD).
METHODS: Polymorphisms R702W, G908R, and 3020insC of NOD2/CARD15; rs2241880 A/G of ATG16L1, and rs11209026 (R381Q) of IL23R gene were assessed in 110 childhood-onset CD, 364 adult-onset CD, and 539 healthy individuals. Analysis of polymorphisms R702W, G908R, and 3020insC of NOD2/CARD15 genotyping was performed by allele specific polymerase chain reaction (PCR) or by PCR-restriction fragment length polymorphism analysis. The polymorphisms rs2241880 A/G of the ATG16L1, and rs11209026 (R381Q) of the IL23R gene in the children's cohort were genotyped by PCR and melting curve analysis whereas adult group genotyping was performed using the Affymetrix Genome-Wide Human SNP Array 5.0 (500K).
RESULTS: The 3020insC allele in NOD2/CARD15 was significantly higher in childhood than in adult-onset CD (P = 0.0067). Association with at least 1 NOD2/CARD15 variant was specific for ileal disease (with or without colonic involvement). Even if the frequency of G allele of the rs2241880 ATG16L1 polymorphism was increased in both paediatric and adult CD patients compared to controls (P = 0.017 and P = 0.001, respectively), no difference was observed between the childhood and the adult cohort. The rare Q allele of IL23R rs11209026 polymorphism was underrepresented in both paediatric and adult CD cases (P = 0.0018 and P = 0.04, respectively) and no difference was observed between the childhood and the adult cohort. The presence of the rs2241880 ATG16L1 and rs11209026 IL23R polymorphisms did not influence disease phenotype.
CONCLUSION: Polymorphism 3020insC in NOD2/CARD15 occurs statistically significantly more often in patients with childhood-onset CD than in patients with adult-onset CD. The ATG16L1 and IL23R variants are associated with susceptibility to CD, but not early-onset disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380008      PMCID: PMC2852824          DOI: 10.3748/wjg.v16.i14.1753

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.

Authors:  Denise K Bonen; Yasunori Ogura; Dan L Nicolae; Naohiro Inohara; Lisa Saab; Tsuyoshi Tanabe; Felicia F Chen; Simon J Foster; Richard H Duerr; Steven R Brant; Judy H Cho; Gabriel Nuñez
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

2.  Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System.

Authors:  Francisco M De la Vega; Katherine D Lazaruk; Michael D Rhodes; Michael H Wenz
Journal:  Mutat Res       Date:  2005-06-03       Impact factor: 2.433

3.  Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.

Authors:  Maria Gazouli; Gerassimos Mantzaris; Athanassios Kotsinas; Panayotis Zacharatos; Efstathios Papalambros; Athanassios Archimandritis; John Ikonomopoulos; Vassilis-G Gorgoulis
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

4.  Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort.

Authors:  Esther Leshinsky-Silver; Amir Karban; Erena Buzhakor; Marcelo Fridlander; Benjamin Yakir; Rami Eliakim; Shimon Reif; Roni Shaul; Mona Boaz; Dorit Lev; Arie Levine
Journal:  Pediatr Res       Date:  2005-09       Impact factor: 3.756

5.  CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease.

Authors:  Subra Kugathasan; Nicole Collins; Karen Maresso; Raymond G Hoffmann; Michael Stephens; Steven L Werlin; Colin Rudolph; Ulrich Broeckel
Journal:  Clin Gastroenterol Hepatol       Date:  2004-11       Impact factor: 11.382

6.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

Authors:  Melvin B Heyman; Barbara S Kirschner; Benjamin D Gold; George Ferry; Robert Baldassano; Stanley A Cohen; Harland S Winter; Patricia Fain; Chris King; Terry Smith; Hashem B El-Serag
Journal:  J Pediatr       Date:  2005-01       Impact factor: 4.406

7.  Association of NOD2/CARD15 variants with Crohn's disease in a Greek population.

Authors:  Maria Gazouli; Panayotis Zacharatos; Gerassimos J Mantzaris; Calypso Barbatis; Ioannis Ikonomopoulos; Athanassios J Archimandritis; John C Lukas; Efstathios Papalambros; Vassilis Gorgoulis
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-11       Impact factor: 2.566

8.  NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease.

Authors:  Batia Weiss; Raanan Shamir; Yoram Bujanover; Mati Waterman; Corina Hartman; Akiva Fradkin; Drora Berkowitz; Ilana Weintraub; Ram Eliakim; Amir Karban
Journal:  J Pediatr       Date:  2004-08       Impact factor: 4.406

9.  Inflammatory bowel disease in children 5 years of age and younger.

Authors:  Petar Mamula; Grzegorz W Telega; Jonathan E Markowitz; Kurt A Brown; Pierre A Russo; David A Piccoli; Robert N Baldassano
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

Review 10.  Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations.

Authors:  Sandra C Kim; George D Ferry
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

View more
  18 in total

Review 1.  ATG16L1: A multifunctional susceptibility factor in Crohn disease.

Authors:  Mohammad Salem; Mette Ammitzboell; Kris Nys; Jakob Benedict Seidelin; Ole Haagen Nielsen
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

Review 2.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

Review 3.  Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.

Authors:  Saleh A Naser; Melissa Arce; Anam Khaja; Marlene Fernandez; Najih Naser; Sammer Elwasila; Saisathya Thanigachalam
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

Review 4.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

Review 5.  Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity.

Authors:  Stephan T Stern; Pavan P Adiseshaiah; Rachael M Crist
Journal:  Part Fibre Toxicol       Date:  2012-06-14       Impact factor: 9.400

6.  Cellular and molecular mechanisms of intestinal fibrosis.

Authors:  Silvia Speca; Ilaria Giusti; Florian Rieder; Giovanni Latella
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

7.  The role of autophagy in Crohn's disease.

Authors:  Paul Henderson; Craig Stevens
Journal:  Cells       Date:  2012-08-03       Impact factor: 6.600

8.  Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.

Authors:  Xiaohua Xue; Pejman Soroosh; Aimee De Leon-Tabaldo; Rosa Luna-Roman; Marciano Sablad; Natasha Rozenkrants; Jingxue Yu; Glenda Castro; Homayon Banie; Wai-Ping Fung-Leung; Luis Santamaria-Babi; Thomas Schlueter; Michael Albers; Kristi Leonard; Alison L Budelsky; Anne M Fourie
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

9.  Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn's disease: A meta-analysis.

Authors:  Wang-Dong Xu; Qi-Bing Xie; Yi Zhao; Yi Liu
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

10.  Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.

Authors:  Xiaohua Xue; Aimee De Leon-Tabaldo; Rosa Luna-Roman; Glenda Castro; Michael Albers; Freddy Schoetens; Samuel DePrimo; Damayanthi Devineni; Thomas Wilde; Steve Goldberg; Olaf Kinzel; Thomas Hoffmann; Anne M Fourie; Robin L Thurmond
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.